Medifast Inc.

13.05
-0.43 (-3.19%)
At close: Apr 01, 2025, 3:59 PM
13.07
0.12%
After-hours: Apr 01, 2025, 08:00 PM EDT

Medifast Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20
Net Income 2.09M 99.42M 143.57M 164.03M 102.86M
Depreciation & Amortization 11.91M 13.11M 10.98M 6.81M 7.27M
Stock-Based Compensation 7.36M 8.19M 11.05M 9.9M 6.8M
Other Working Capital 13.08M -8.28M -39.54M 39.01M 5.17M
Other Non-Cash Items 10.52M 5.46M 8.24M 5.16M 1.09M
Deferred Income Tax -7.4M 1.21M -924K -3.71M 601K
Change in Working Capital n/a 20.28M 21.65M -87.65M 26.58M
Operating Cash Flow 24.48M 147.66M 194.57M 94.55M 145.2M
Capital Expenditures -7.45M -6.48M -16.68M -34.21M -5.89M
Acquisitions n/a n/a n/a n/a n/a
Purchase of Investments -46.59M -54.56M n/a n/a n/a
Sales Maturities Of Investments 27.43M n/a 5.27M 5.14M 4.61M
Other Investing Acitivies 95K n/a 5.27M 5.14M 4.61M
Investing Cash Flow -26.52M -61.05M -11.41M -29.06M -1.28M
Debt Repayment n/a n/a n/a n/a n/a
Common Stock Repurchased -836K -6.96M -127.96M -62.09M -5.55M
Dividend Paid -715K -73.02M -71.62M -63.86M -53.19M
Other Financial Acitivies 36K 188K n/a 811K 1.6M
Financial Cash Flow -1.51M -79.79M -199.58M -125.13M -57.14M
Net Cash Flow -3.51M 6.75M -16.49M -59.54M 86.75M
Free Cash Flow 17.02M 141.17M 177.89M 60.34M 139.31M